A comparative study of idarubicin 12 mg/m² and 8 mg/m² combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients

Li ZhouDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of China

Xin LiuDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of China

Huilan LiuDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of China

Weibo ZhuDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of China

Xiaoyan CaiDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of China

Kaidi SongDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of China

Changcheng ZhengDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of China

Baolin TangDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of China

Zimin SunDepartment of Hematology, Anhui Provincial Hospital, Hefei, Anhui, People’s Republic of ChinaCorrespondence[email protected]

Your download is now in progress and you may close this window